Pharmaron Biologics
San Diego, CA · Shaoxing, China, Liverpool, UK, Ningbo China
No confirmed program data — ClinicalTrials.gov verification pending
· Last scored 2026-09-07
86.9
Signal Score
✓ FDA Inspections (3)
○ Clinical Trials
○ SEC Filings
✓ Press (1)
○ EMA GMP
○ MHRA GMP
Quick Facts: Pharmaron Biologics
- Signal Score
- 86.9/100 (as of 2026-09-07)
- Quality Compliance
- 100.0/100
- Headquarters
- San Diego, CA · Shaoxing, China, Liverpool, UK, Ningbo China
- Modalities
- AAV, Lentiviral, Plasmid, mAb, Antibody, Recombinant Protein, Biosimilars
- Active Programs
- Data pending
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About Pharmaron Biologics
Chinese CRO/CDMO with US CGT operations.
Signal Score & Pillar Breakdown
Scores are being republished.
Scores are being republished under methodology v3.3. The score shown is the last complete v3.2 result, which is also what directory listings and search results show. A pillar breakdown is not shown because the current one is computed under v3.3 and would not explain a v3.2 score. Regulatory evidence below is current.
Quality Compliance
100.0
FDA Inspections3 on record
Warning Letters0
Last InspectionNo Action Indicated (NAI) (2025-07-17)
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesAAV, Lentiviral, Plasmid, mAb, Antibody, Recombinant Protein, Biosimilars
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability
83.0
Profile-based financial assessment
SEC FilingsPrivate company
Capacity
68.0
Capacity status: Available
StatusAvailable
Recent Press1 articles
Pharmaron Biologics FDA Inspection History
2025-07
2025-01
2024-09
NAI
VAI
OAI
| Date | Site | Type | Observations | Classification |
|---|---|---|---|---|
| 2025-07-17 |
Pharmaron Manufacturing Services (US) LLC
Coventry, Rhode Island
Facility-linked
|
Drug Quality Assurance | No | No Action Indicated (NAI) |
| 2025-01-17 |
Pharmaron (Exton) Lab Services LLC
Exton, Pennsylvania
Facility-linked
|
Human Cellular, Tissue, and Gene Therapies | No | No Action Indicated (NAI) |
| 2024-09-27 |
Pharmaron (Exton) Lab Services LLC
Exton, Pennsylvania
Facility-linked
|
Bioresearch Monitoring | No | No Action Indicated (NAI) |
Source: FDA Data Dashboard · Retrieved Oct 07, 2026
Recent News 1 articles
How HTPD transforms AAV process optimization and scale-up - News-Medical
Frequently Asked Questions About Pharmaron Biologics
How many FDA inspections does Pharmaron Biologics have on record?
CDMO Signal tracks 3 FDA inspections for Pharmaron Biologics, sourced from the FDA inspection database. See the full inspection history above.
Has Pharmaron Biologics received an FDA warning letter?
CDMO Signal has no FDA warning letters on record for Pharmaron Biologics.
What is Pharmaron Biologics's CDMO Signal Score?
Pharmaron Biologics has a Signal Score of 87/100, based on quality, operations, financial stability, and capacity data.
Evaluating Pharmaron Biologics for a manufacturing program?
Use the free AI matchmaker to compare Pharmaron Biologics against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
Charles River Laboratories
Newbury Park, CA · Memphis, TN · Keele, UK · Rockville, MD
Signal Score: 90.9
CAR-T, Cell Therapy, Gene Editing, Plasmid, AAV, Lentiviral, ADC
ReciBioPharm
Keele, UK · Sodertalje, SE
Signal Score: 88.0
AAV, Lentiviral, Plasmid, mRNA
Thermo Fisher Scientific
Plainville, MA · Alachua, FL · Cambridge, MA
Signal Score: 81.0
AAV, Lentiviral, Plasmid DNA, Adenoviral, Plasmid
AGC Biologics
Longmont, CO · Milan, IT · Copenhagen, DK · Chiba, JP
Signal Score: 78.6
CAR-T, Cell Therapy, AAV, Lentiviral, ADC, Monoclonal Antibody, Recombinant Protein
Lonza Biologics
Houston, TX · Portsmouth, NH · Geleen, NL · Basel, CH
Signal Score: 73.0
AAV, Lentiviral, Cell Therapy, mRNA, Monoclonal Antibody, Recombinant Protein